Matches in Nanopublications for { ?s ?p " Atorvastatin and other statins are considered first-line treatment options for dyslipidemia. The increasing use of this class of drugs is largely attributed to the rise in cardiovascular diseases (CVD) An elevated cholesterol level (elevated low-density lipoprotein (LDL) levels) is a significant risk factor for the development of CVD. Statins were shown to reduce the incidences of all-cause mortality, including fatal and non-fatal CVD, as well as the need for surgical revascularization or angioplasty following a" ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- assertion wasQuotedFrom " Atorvastatin and other statins are considered first-line treatment options for dyslipidemia. The increasing use of this class of drugs is largely attributed to the rise in cardiovascular diseases (CVD) An elevated cholesterol level (elevated low-density lipoprotein (LDL) levels) is a significant risk factor for the development of CVD. Statins were shown to reduce the incidences of all-cause mortality, including fatal and non-fatal CVD, as well as the need for surgical revascularization or angioplasty following a" provenance.